Products for Research Use Only
RegisterLogin

DOTA-Octreotide

CAT: 0804-HY-P10273Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10273Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOTA-Octreotide is composed of chelator DOTA and Octreotide. DOTA-Octreotide is used for research of cancer, through combination with radioactive elements. DOTA-Octreotide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
CAS Number
209277-09-8
UNSPSC
12352209
Target
Biochemical Assay Reagents; Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dota-octreotide.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](NC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)CC3=CC=CC=C3)=O)=O)CC4=CC=CC=C4)N[C@@H]1CC5=CNC6=CC=CC=C56
Molecular Formula
C65H92N14O17S2
Molecular Weight
1405.64
References & Citations
[1]Bodei L, et al., Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2004 Jul;31 (7) :1038-46.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
RDC Peptide

Related Products

CatalogName
HY-P0036-01Octreotide
HY-163040DOTA-Tyr-Lys-DOTA
HY-P0036S2Octreotide-d8
HY-P0036BOctreotide (pamoate)
HY-17365-01Octreotide (acetate)
HY-P5085Acetyl-Octreotide
HY-P0036AOctreotide (dihydrochloride)
HY-P11254DOTA-FAPT
HY-W678394-01DOTA-Thiol
HY-163039DOTA-biotin

Alternative Products

CatalogName
GTR19259587DOTA-Octreotide
4043535.0001DOTA- (Tyr³) -Octreotide
H-4136.0005DOTA-(Tyr3)-Octreotide
TP3068-01DOTA-Octreotide TFA
BA2745-10Octreotide

Popular Products